131![Cimzia(ß (certolizumab pegol) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIAQ! safely and effectively. See full prescribing information for CIMZIA. Cimzia(ß (certolizumab pegol) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIAQ! safely and effectively. See full prescribing information for CIMZIA.](https://www.pdfsearch.io/img/bb1ee7514837b1bde6d9b6848f33649e.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2010-08-10 12:14:51
|
---|
132![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIA® safely and effectively. See full prescribing information for CIMZIA. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIA® safely and effectively. See full prescribing information for CIMZIA.](https://www.pdfsearch.io/img/9ea18a74558104ffe2ebecdd4825a226.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-08-31 14:12:04
|
---|
133![Providing Affordable Treatment: Biosimilar Agents Dae Hyun Yoo, M.D. Rheumatology and Internal Medicine Providing Affordable Treatment: Biosimilar Agents Dae Hyun Yoo, M.D. Rheumatology and Internal Medicine](https://www.pdfsearch.io/img/f5c39a0779eb3d45247694ed5aac258d.jpg) | Add to Reading ListSource URL: aplarcongress.orgLanguage: English - Date: 2014-04-23 05:34:26
|
---|
134![APLAR 2014, Cebu, April 3, 2014 Rheumatoid Arthritis treatment with biologics Tsutomu Takeuchi, MD.PhD. APLAR 2014, Cebu, April 3, 2014 Rheumatoid Arthritis treatment with biologics Tsutomu Takeuchi, MD.PhD.](https://www.pdfsearch.io/img/3f8e3c69b0ed1df4ef4c6a13de80f81c.jpg) | Add to Reading ListSource URL: aplarcongress.orgLanguage: English - Date: 2014-04-23 05:32:38
|
---|
135![](https://www.pdfsearch.io/img/8b3cb0be1bf8d0b13b0ae26a55bba6eb.jpg) | Add to Reading ListSource URL: aplarcongress.orgLanguage: English - Date: 2014-03-27 11:16:24
|
---|
136![Clinical Practice Guideline Clinical Practice Guideline](https://www.pdfsearch.io/img/f5e626824bfd74dfec0b71c79ddb0705.jpg) | Add to Reading ListSource URL: www.albertahealthservices.caLanguage: English - Date: 2013-03-05 15:53:51
|
---|
137![Boxed Warning and new recommendations to decrease risk of hepatitis B reactivation with the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab) and Rituxan (rituximab) Safety Announcement[removed]The U.S. F Boxed Warning and new recommendations to decrease risk of hepatitis B reactivation with the immune-suppressing and anti-cancer drugs Arzerra (ofatumumab) and Rituxan (rituximab) Safety Announcement[removed]The U.S. F](https://www.pdfsearch.io/img/4bac5cefa259bfa06196fc913d3e8c1a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
138![DSQ Drug Safety Quarterly Vo l[removed]Wi n te r[removed] DSQ Drug Safety Quarterly Vo l[removed]Wi n te r[removed]](https://www.pdfsearch.io/img/0d9f68fdd5c34847da1861385e8df1d6.jpg) | Add to Reading ListSource URL: www.rheumatology.orgLanguage: English |
---|
139![DSQ Drug Safety Quarterly Vo l[removed]No v e m b e r[removed] DSQ Drug Safety Quarterly Vo l[removed]No v e m b e r[removed]](https://www.pdfsearch.io/img/00e9ad52cb21de618bd7053f9a61e21e.jpg) | Add to Reading ListSource URL: www.rheumatology.orgLanguage: English |
---|
140![DSQ Drug Safety Quarterly Vo l[removed]Sp ri n g[removed] DSQ Drug Safety Quarterly Vo l[removed]Sp ri n g[removed]](https://www.pdfsearch.io/img/68f3941bffb7635250b38d3726546ae8.jpg) | Add to Reading ListSource URL: www.rheumatology.orgLanguage: English |
---|